Argent Biopharma (H5O0) Financial Statements
Argent Biopharma Financial Overview
Argent Biopharma's market cap is currently $1.85M. The company's EPS TTM is $-0.16; its P/E ratio is -0.23; Argent Biopharma has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Jun 25 | Jun 24 | Jun 23 | Jun 22 | Jun 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 161.19K | $ 583.45K | $ 891.08K | $ 3.39M | $ 4.73M |
| Gross Profit | $ -204.21K | $ 446.32K | $ 203.70K | $ 1.45M | $ 1.81M |
| Operating Income | $ -7.39M | $ -15.44M | $ -18.26M | $ -15.60M | $ -14.26M |
| EBITDA | $ -7.23M | $ -17.00M | $ -15.77M | $ -20.04M | $ -16.54M |
| Net Income | $ -7.71M | $ -17.84M | $ -17.53M | $ -20.82M | $ -16.77M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 141.46K | $ 1.02M | $ 702.87K | $ 239.82K | $ 1.79M |
| Total Assets | $ 1.29M | $ 2.47M | $ 10.79M | $ 9.88M | $ 23.55M |
| Total Debt | $ 9.59M | $ 8.29M | $ 1.04M | $ 575.14K | $ 4.39M |
| Net Debt | $ 9.45M | $ 7.26M | $ 341.85K | $ 335.32K | $ 2.61M |
| Total Liabilities | $ 10.74M | $ 11.10M | $ 16.61M | $ 18.02M | $ 13.66M |
| Stockholders' Equity | $ -9.45M | $ -8.63M | $ -5.15M | $ -7.51M | $ 11.23M |
| Cash Flow | |||||
| Free Cash Flow | $ -4.03M | $ -9.28M | $ -14.80M | $ -12.18M | $ -14.85M |
| Operating Cash Flow | $ -4.03M | $ -9.28M | $ -14.66M | $ -11.99M | $ -12.16M |
| Investing Cash Flow | $ -721.00 | $ 208.83K | $ -140.12K | $ 606.20K | $ -1.11M |
| Financing Cash Flow | $ 3.14M | $ 9.39M | $ 15.27M | $ 9.73M | $ 9.74M |
Currency in AUD